These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 26560472)
61. Dietary Oxalate Intake and Kidney Outcomes. Bargagli M; Tio MC; Waikar SS; Ferraro PM Nutrients; 2020 Sep; 12(9):. PubMed ID: 32887293 [TBL] [Abstract][Full Text] [Related]
62. Externalization of phosphatidylserine via multidrug resistance 1 (MDR1)/P-glycoprotein in oxalate-treated renal epithelial cells: implications for calcium oxalate urolithiasis. Li YH; Yu SL; Gan XG; Pan SH; Teng YQ; An RH Int Urol Nephrol; 2016 Feb; 48(2):175-81. PubMed ID: 26560472 [TBL] [Abstract][Full Text] [Related]
63. MRP-1 and BCRP Promote the Externalization of Phosphatidylserine in Oxalate-treated Renal Epithelial Cells: Implications for Calcium Oxalate Urolithiasis. Li Y; Yu S; Gan X; Zhang Z; Wang Y; Wang Y; An R Urology; 2017 Sep; 107():271.e9-271.e17. PubMed ID: 28577929 [TBL] [Abstract][Full Text] [Related]
64. Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease. Cao LC; Jonassen J; Honeyman TW; Scheid C Am J Nephrol; 2001; 21(1):69-77. PubMed ID: 11275638 [TBL] [Abstract][Full Text] [Related]
65. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells. Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013 [TBL] [Abstract][Full Text] [Related]
66. [CIK cells acquired multidrug resistance and maintained cytotoxic activity to tumor cells after mdr1 gene transfection]. Yang YH; Li HF; Shi YJ; Wang YQ; Zhang Y; Wang YJ; Zhu P Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):617-20. PubMed ID: 14761606 [TBL] [Abstract][Full Text] [Related]
67. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. Khan SR J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011 [TBL] [Abstract][Full Text] [Related]
68. Oxalate impairs aminophospholipid translocase activity in renal epithelial cells via oxidative stress: implications for calcium oxalate urolithiasis. Yu SL; Gan XG; Huang JM; Cao Y; Wang YQ; Pan SH; Ma LY; Teng YQ; An RH J Urol; 2011 Sep; 186(3):1114-20. PubMed ID: 21784463 [TBL] [Abstract][Full Text] [Related]
69. Three pathways for human kidney stone formation. Coe FL; Evan AP; Worcester EM; Lingeman JE Urol Res; 2010 Jun; 38(3):147-60. PubMed ID: 20411383 [TBL] [Abstract][Full Text] [Related]
70. Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes. Contreras FX; Sánchez-Magraner L; Alonso A; Goñi FM FEBS Lett; 2010 May; 584(9):1779-86. PubMed ID: 20043909 [TBL] [Abstract][Full Text] [Related]
71. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Tsujihata M Int J Urol; 2008 Feb; 15(2):115-20. PubMed ID: 18269444 [TBL] [Abstract][Full Text] [Related]